Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Paolo A. Muraro(Imperial College Healthcare NHS Trust), George E. Georges(Northwestern University), Luca Massacesi(National Institute of Neurological Disorders and Stroke), Mark S. Freedman(University of Ottawa), Xiaobo Zhong(Icahn School of Medicine at Mount Sinai), Harold Atkins(University of Ottawa), Francesca Gualandi(Ospedale Policlinico San Martino), Αthanasios Fassas(G. Papanikolaou General Hospital), Belinda Pinto Simões(Universidade de São Paulo), James D. Bowen(Swedish Medical Center), Riccardo Saccardi(Azienda Ospedaliero-Universitaria Careggi), Nelson Hamerschlak(Hospital Israelita Albert Einstein), Maria Pia Sormani(University of Genoa), Richard A. Nash(Colorado Blood Cancer Institute), Steven Z. Pavletic(National Institutes of Health), Manuela Badoglio(Sorbonne Université), Eva Havrdová(Charles University), Vasilios Κ. Kimiskidis(Aristotle University of Thessaloniki), Marcelo C. Pasquini(Cleveland Clinic), Marek Trněný(Charles University), Lin Zhu(Valley Health System), Jian Ouyang(Shanghai Academy of Science & Technology), Tomáš Kozák(The University of Texas System), Albert Saiz(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Montserrat Rovira(Humanitas University), Dominique Farge(Hôpital Saint-Louis), Daniela A. Moraes
JAMA Neurology
February 27, 2017
Cited by 274


Related Papers